Latest papers

Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-gamma pathway activation in swine aortic valve endothelium.

[What comes after docetaxel?].

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design.

Treatment of castration-resistant prostate cancer: updates on therapeutics targeting the androgen receptor signaling pathway.

[New drugs in metastatic castration-resistant prostate cancer].

Prolactin released in vitro from the pituitary of lactating, pregnant, and steroid-treated female or male rats stimulates prolactin secretion from pituitary lactotropes of male rats.

Do we really need new trials on fulvestrant in prostate cancer?

[Seminoma necrosis by testicular torsion].

Small molecule screening reveals a transcription-independent pro-survival function of androgen receptor in castration-resistant prostate cancer.

HE3235 inhibits growth of castration-resistant prostate cancer.

A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Both endogenous and exogenous testosterone decrease myocardial STAT3 activation and SOCS3 expression after acute ischemia and reperfusion.

Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice.

Androgen Regulates the Sexually Dimorphic Gastrin-Releasing Peptide System in the Lumbar Spinal Cord that Mediates Male Sexual Function

[The heart and the head].

[Errors and restlessness around the theme of piglet castration].

A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer.

Gender-Dependent Survival of Allogeneic Trophoblast Stem Cells in Liver

Regulation of Human CYP2C18 and CYP2C19 in Transgenic Mice: Influence of Castration, Testosterone, and Growth Hormone

[Castrati--everything to achieve fame].